Desai, M. Y., Wolski, K., Owens, A., Geske, J. B., Saberi, S., Wang, A., … VALOR-HCM Investigators. (2025). Correction to: Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results from VALOR-HCM. Circulation, 151(19), e1001. https://doi.org/10.1161/CIR.0000000000001339

Desai, Milind Y., Kathy Wolski, Anjali Owens, Jeffrey B. Geske, Sara Saberi, Andrew Wang, Mark Sherrid, et al. “Correction to: Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results from VALOR-HCM.” Circulation 151, no. 19 (May 13, 2025): e1001. https://doi.org/10.1161/CIR.0000000000001339.

Desai MY, Wolski K, Owens A, Geske JB, Saberi S, Wang A, et al. Correction to: Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results from VALOR-HCM. Circulation. 2025 May 13;151(19):e1001.

Desai, Milind Y., et al. “Correction to: Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results from VALOR-HCM.” Circulation, vol. 151, no. 19, May 2025, p. e1001. Pubmed, doi:10.1161/CIR.0000000000001339.

Desai MY, Wolski K, Owens A, Geske JB, Saberi S, Wang A, Sherrid M, Cremer PC, Lakdawala NK, Tower-Rader A, Fermin D, Naidu SS, Smedira NG, Schaff H, Gong Z, Mudarris L, Lampl K, Sehnert AJ, Nissen SE, VALOR-HCM Investigators. Correction to: Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results from VALOR-HCM. Circulation. 2025 May 13;151(19):e1001.